Momelotinib in VEXAS Syndrome

Clinical trial NCT07098936 · RECRUITING

Trial details

NCT number: NCT07098936
Sponsor: Groupe Francophone des Myelodysplasies
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

VEXAS Syndome Myelo Dysplastic Syndrome

Start date: 2025-11-25
Primary completion: 2028-06-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.